Impact Factor
Global reach, higher impact
Review Efferocytosis in heart failure: Mechanisms, dysregulation and therapeutic potential Full text PDF
Review Functionalized metallic nanomaterials, nanozymes and nanomotors for emerging tumor diagnosis and treatment: from design to theranostics strategies Full text PDF
Review Bacterial extracellular vesicles as multifaceted regulators of human diseases and emerging therapeutic platforms Full text PDF
Review The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025) Full text PDF
Research Paper Mitochondria-targeting organoselenium theranostic radioprotectors for simultaneous treatment and imaging of radiation-induced liver injury Full text PDF
Research Paper A dual functional theranostic microneedle patch for immunomodulation and real time monitoring in diabetic wound therapy Full text PDF
Issue 10; 2026
Founding Editor-in-Chief:
Prof. Xiaoyuan (Shawn) Chen, PhD
Profile
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
- Theranostics is indexed by Science Citation Index (SCI) and MEDLINE. (Full index information)
- Full texts of articles in PubMed Central and Europe PMC. Abstracts in PubMed.
- (For NIH-funded researchers) Save time by submitting your paper to us - this journal is in full compliance with NIH Public Access Requirement.
Efferocytosis in heart failure: Mechanisms, dysregulation and therapeutic potential
Heart failure (HF) remains one of the leading health problems globally. It is often characterized by unresolved inflammation, adverse cardiac remodeling, and tissue damage. Efferocytosis, the process by which phagocytes clear apoptotic cells, is a key process that helps to resolve inflammation and maintain tissue homeostasis. In the healthy heart, efferocytosis ensures the proper removal of apoptotic cardiac cells (e.g., cardiac fibroblasts and cardiomyocytes) ...